Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway
Abstract Background Congenital disorders of glycosylation (CDG) are rare diseases with impaired glycosylation and multiorgan disfunction, including hemostatic and inflammatory disorders. Factor XII (FXII), the first element of the contact phase, has an emerging role in hemostasia and inflammation. F...
Main Authors: | Raquel López-Gálvez, María Eugenia de la Morena-Barrio, Alberto López-Lera, Monika Pathak, Antonia Miñano, Mercedes Serrano, Delphine Borgel, Vanessa Roldán, Vicente Vicente, Jonas Emsley, Javier Corral |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01564-9 |
Similar Items
-
Anesthetic management of a child with phosphomannomutase-2 congenital disorder of glycosylation (PMM2-CDG)
by: Wataru Sakai, et al.
Published: (2017-02-01) -
Mannose supplementation in PMM2-CDG
by: Roman Taday, et al.
Published: (2021-08-01) -
Genotype-Phenotype Correlations in PMM2-CDG
by: Laurien Vaes, et al.
Published: (2021-10-01) -
Identification through exome sequencing of the first PMM2-CDG individual of Mexican mestizo origin
by: C.A. González-Domínguez, et al.
Published: (2020-12-01) -
Evaluation of Cell Models to Study Monocyte Functions in PMM2 Congenital Disorders of Glycosylation
by: Paola de Haas, et al.
Published: (2022-05-01)